Evidence-Based Innovation
Research & publications
Peer-reviewed research, news articles and scientific publications on our technologies in wound closure and wound therapy.
Scientific information notice: the publications on this page are provided as scientific information for healthcare professionals. Some describe investigational methods, including regulated oxygen-enriched negative pressure treatment (ROI-NPT) and targeted in-situ antibiotic administration (CITA), which are not FDA-cleared indications of any IVT Medical device; their safety and effectiveness for those uses have not been established. The FDA-cleared indication of Vcare α® (K121817) and MeCare α® (K260426) is regulated negative pressure wound therapy for wound management in professional healthcare facilities. Authors of several publications include Prof. Moris Topaz, the inventor of these technologies, who is the CEO and a shareholder of IVT Medical Ltd.